pum1 primary antibody (ABclonal Biotechnology)
Structured Review

Pum1 Primary Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pum1 primary antibody/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "PUM1 knockdown prevents tumor progression by activating the PERK/eIF2/ATF4 signaling pathway in pancreatic adenocarcinoma cells"
Article Title: PUM1 knockdown prevents tumor progression by activating the PERK/eIF2/ATF4 signaling pathway in pancreatic adenocarcinoma cells
Journal: Cell Death & Disease
doi: 10.1038/s41419-019-1839-z
Figure Legend Snippet: a PUM1 mRNA expression levels in PAAD tissues (T) and normal tissues (N) analyzed by gene expression profiling interactive analysis (GEPIA). * P < 0.05. b Analysis of the relationship between PUM1 mRNA expression and overall survival of PAAD patients analyzed using The Cancer Genome Atlas (TCGA)
Techniques Used: Expressing, Gene Expression
Figure Legend Snippet: a Representative images of PUM1 expression by immunohistochemistry (IHC) analysis in tissue microarrays representing 60 PDAC patients. b Comparison of total scores for PUM1 assessment on tissue microarrays slides. Total score = positive staining scores × staining intensity score. * P < 0.05. c The overall survival rate of patients with PDAC was evaluated based on PUM1 expression using Kaplan–Meier analysis ( n = 60, P = 0.022)
Techniques Used: Expressing, Immunohistochemistry, Comparison, Staining
Figure Legend Snippet: The relationship between PUM1 protein levels and clinic characteristics of patients with pancreatic adenocarcinoma
Techniques Used: Expressing
Figure Legend Snippet: PUM1 mRNA ( a ) and protein ( b ) expression levels in PDAC cell lines (BxPC-3, AsPC-1, MIA PaCa-2, and PANC-1) and human pancreatic duct epithelial cells HPDE6-C7. c PUM1 expression levels in cells infected with lentivirus expressing the shRNA of PUM1 (shPUM1) or negative (NC) control empty lentivirus. d , e Effect of PUM1 knockdown on the OD values at 490 nm. f Effect of PUM1 knockdown on early apoptosis rate. b , c , f The representative graphs are on the left, and the statistical results are on the right. n = 3, * P < 0.05, for a – f
Techniques Used: Expressing, Infection, shRNA, Control, Knockdown
Figure Legend Snippet: Effect of PUM1 knockdown on cell migration ( a ) and invasion ( b ) detected by Transwell assays. Representative graphs (left). Bar graph showing the statistical result of migratory or invasive cells (right). c Effect of PUM1 knockdown on the expression of MMP9, VEGF, vimentin, and E-cadherin. Representative graphs of western blotting (left). Relative protein expression in reference to GAPDH (right). n = 3, * P < 0.05, for a – c
Techniques Used: Knockdown, Migration, Expressing, Western Blot
Figure Legend Snippet: a PUM1 expression levels in tumors formed by the shPUM1 or NC group cells. b , c Effect of PUM1 knockdown on the growth of subcutaneous xenograft tumor. b Pictures of subcutaneous xenograft tumor. c Tumor growth curve. n = 8, * P < 0.05. d , e Effect of PUM1 knockdown on lung metastases examined by hematoxylin and eosin staining, or Ki67 expression detected by immunohistochemistry in the lung tissues of a lung metastasis mouse model
Techniques Used: Expressing, Knockdown, Staining, Immunohistochemistry
Figure Legend Snippet: Volcano plot ( a ), scatter plot ( b ), and cluster gram ( c ) of the cDNA microarrays. d Effect of PUM1 knockdown on the expression of key components of the eIF2 signaling pathway. Left: Representative graphs of western blotting. Right: Statistical result of the relative protein expression in reference to GAPDH. n = 3, * P < 0.05
Techniques Used: Knockdown, Expressing, Western Blot
Figure Legend Snippet: a Representative pictures showing p-PERK levels in 60 PDAC tissues on tissue microarray examined by immunohistochemical analysis. b Linear regression analysis showing the correlation of PUM1 and p-PERK levels in PDAC tissues ( n = 60)
Techniques Used: Microarray, Immunohistochemical staining
